MedChunk
Medically reviewed

Juvenile Ankylosing Spondylitis: Causes and Treatment

Learn what causes juvenile ankylosing spondylitis, how it affects children and teens, and which medicines, exercises, and therapies help manage symptoms.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 13 min read

Juvenile ankylosing spondylitis (JAS) is a type of arthritis that causes swelling and pain in the joints of children and teenagers. Its exact cause is unknown, but genes and other factors may play a role. There is no cure, but medicines, physical therapy, and regular exercise can help control inflammation, reduce pain, and protect joint movement.

How does juvenile ankylosing spondylitis affect the body?

Juvenile ankylosing spondylitis is a long-term inflammatory disease that mainly affects the spine, the joints connecting the spine to the pelvis, and the places where tendons and ligaments attach to bones. These attachment points are called entheses.

The disease belongs to a group of conditions known as spondyloarthritis. In children, it may initially resemble enthesitis-related arthritis, a form of juvenile idiopathic arthritis that affects joints and tendon attachment sites.

Unlike adults, who often develop lower back pain early, children may first experience inflammation in their hips, knees, ankles, or heels. Pain and stiffness in the lower back may develop later.

The Arthritis Foundation explains that JAS can affect areas beyond the joints, including the eyes and digestive tract. Persistent inflammation may also damage joints over time, making early recognition and treatment important.

What causes juvenile ankylosing spondylitis?

Researchers have not identified one specific cause of juvenile ankylosing spondylitis. Current evidence suggests that genetic susceptibility and environmental factors may contribute to its development.

Genetic factors and the HLA-B27 gene

One of the strongest known associations is with HLA-B27, a genetic marker involved in how the immune system recognizes certain substances.

Children who carry HLA-B27 have an increased likelihood of developing ankylosing spondylitis compared with those who do not carry it. However, many people with this marker never develop the disease.

A family history of ankylosing spondylitis or related inflammatory conditions can also increase susceptibility.

According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), both genetic and environmental influences are thought to contribute to ankylosing spondylitis. The presence of HLA-B27 alone does not determine whether someone will develop the condition.

Immune system inflammation

Juvenile ankylosing spondylitis involves inflammation in joints and surrounding tissues. This inflammation can produce pain, swelling, and stiffness.

When inflammation continues over time, it may affect joint movement and contribute to structural changes. In some people, long-standing inflammation in the spine can eventually lead to new bone formation and the joining, or fusion, of spinal bones.

Possible environmental triggers

Researchers suspect that outside factors, including certain infections or other environmental exposures, may help trigger the disease in genetically susceptible children.

However, no specific infection or exposure has been established as the cause of juvenile ankylosing spondylitis. It is not considered a contagious condition.

Which children may be more likely to develop JAS?

Several characteristics are associated with a higher likelihood of juvenile ankylosing spondylitis. These are risk factors, not definite causes.

  • HLA-B27 positivity: Children carrying this genetic marker have an increased susceptibility.
  • Family history: Having relatives with ankylosing spondylitis or related inflammatory arthritis may increase risk.
  • Sex: Juvenile ankylosing spondylitis is diagnosed more frequently in boys than girls.
  • Related inflammatory conditions: Spondyloarthritis can be associated with psoriasis and inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.

These associations do not mean that a child with one or more risk factors will necessarily develop arthritis.

What are the early signs of juvenile ankylosing spondylitis?

Symptoms often develop gradually. In younger patients, discomfort in the legs or feet may appear before the typical lower back symptoms associated with adult ankylosing spondylitis.

Possible symptoms include:

  • Pain or swelling in the knees, ankles, or hips.
  • Heel pain, particularly around tendon attachment points.
  • Morning stiffness or difficulty moving comfortably after resting.
  • Lower back or buttock pain, especially at night or early in the morning.
  • Joint stiffness that improves with gentle movement.
  • Tiredness that interferes with school or regular activities.
  • Reduced flexibility or difficulty participating in physical activities.

These symptoms can occur with several childhood conditions. Persistent joint pain, swelling, unexplained limping, or stiffness deserves evaluation by a healthcare professional.

Can JAS affect the eyes or digestive system?

Yes. Some children develop inflammation outside the joints.

One important complication is uveitis, inflammation inside the eye. It may cause eye pain, redness, sensitivity to light, or blurred vision. A child who develops these symptoms should receive urgent eye assessment because untreated inflammation can threaten vision.

Some affected children may also experience digestive symptoms associated with inflammatory bowel disease, including ongoing abdominal pain or diarrhea.

How do doctors diagnose juvenile ankylosing spondylitis?

A pediatric rheumatologist, a specialist in children's inflammatory joint diseases, usually evaluates suspected juvenile ankylosing spondylitis.

Diagnosis is based on the overall pattern of symptoms, medical and family history, physical examination, and selected tests. No single blood test can establish the diagnosis.

Physical examination and medical history

The doctor may examine the child's spine, hips, knees, ankles, and feet for swelling, tenderness, or restricted movement. They may also assess posture and ask whether stiffness improves with activity.

Questions about symptom duration, morning stiffness, nighttime pain, and family history help identify patterns of inflammatory arthritis.

Blood tests and imaging

Blood tests may include HLA-B27 testing and inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).

These results provide useful information but must be interpreted alongside symptoms and examination findings.

Imaging may be needed when inflammation of the spine or sacroiliac joints is suspected. X-rays can reveal certain joint changes, while magnetic resonance imaging (MRI) may identify inflammation before those changes become visible on X-rays.

The NIAMS guidance on diagnosis and treatment emphasizes combining medical history, examination, laboratory findings, and imaging rather than relying on one test.

How is juvenile ankylosing spondylitis treated?

Treatment aims to control inflammation, relieve pain, maintain flexibility, and reduce the chance of permanent joint damage. The plan depends on the child's age, affected joints, disease activity, other medical conditions, and response to treatment.

A pediatric rheumatologist generally coordinates care, often with support from a physical therapist and other specialists when necessary.

1. Nonsteroidal anti-inflammatory drugs (NSAIDs)

NSAIDs are commonly used as an initial treatment because they reduce pain and inflammation.

Examples include ibuprofen and naproxen. A healthcare professional determines which medicine is appropriate and how it should be used based on the child's age, weight, medical history, and other medicines.

Although these medicines can improve symptoms, they may cause side effects, including stomach irritation and kidney-related problems. Children who need ongoing treatment require medical supervision.

2. Biologic medicines for persistent inflammation

When inflammation remains active despite initial treatment, a pediatric rheumatologist may recommend a biologic medicine.

Biologics target specific parts of the immune system involved in inflammation. Tumor necrosis factor (TNF) inhibitors are an important treatment option for certain children with persistent inflammatory joint disease, including sacroiliitis or enthesitis.

Examples of TNF inhibitors used in pediatric inflammatory arthritis include adalimumab and etanercept. The choice depends on the child's specific condition, accompanying symptoms, age, and local prescribing approvals.

Before starting a biologic, clinicians assess infection risks and arrange relevant screening. Treatment also requires monitoring because these medicines can increase susceptibility to infections.

The Pediatric Orthopaedic Society of North America identifies TNF-targeting treatment as an effective disease-modifying option for juvenile spondyloarthritis.

3. Disease-modifying antirheumatic drugs (DMARDs)

Some children may receive conventional disease-modifying medicines, such as sulfasalazine or methotrexate, particularly when inflammation affects joints outside the spine.

These medicines are not equally effective for every type of involvement. Conventional DMARDs generally have a limited role in controlling inflammation specifically affecting the spine and sacroiliac joints.

When sacroiliitis remains active despite NSAID treatment, biologic treatment is often considered rather than methotrexate alone.

The pediatric rheumatologist selects treatment according to the pattern of inflammation and the child's overall health.

4. Corticosteroid treatment

Corticosteroids are powerful anti-inflammatory medicines that may be used in selected situations.

A clinician may recommend an injection into a particularly inflamed joint or a short course of medicine while another treatment begins working.

Long-term systemic corticosteroid treatment is generally avoided when possible because of potential side effects, including effects on growth and bone health in children.

5. Physical therapy and exercise

Physical therapy is an important part of managing juvenile ankylosing spondylitis. It helps children maintain flexibility, muscle strength, posture, and everyday mobility.

A pediatric physical therapist can develop an exercise program suited to the child's symptoms and physical abilities.

Activities may include:

  • Gentle stretching to maintain joint flexibility.
  • Strengthening exercises for the back and supporting muscles.
  • Walking or swimming to encourage comfortable movement.
  • Posture exercises to support healthy spinal positioning.
  • Range-of-motion exercises for affected joints.

According to the NHS guidance on ankylosing spondylitis treatment, regular exercise and physiotherapy can improve posture and spinal movement while helping reduce stiffness. Although this guidance mainly addresses ankylosing spondylitis generally, the same principles of supervised movement are relevant to children, with age-appropriate adjustments.

Activities may need modification during painful flares. A therapist can help the family balance activity with comfort and joint protection.

6. Is surgery ever necessary?

Surgery is rarely required for children with juvenile ankylosing spondylitis.

It may be considered in unusual situations involving major joint damage or serious structural problems that affect movement and daily functioning.

Most children are managed using medicines, exercise, rehabilitation, and regular specialist follow-up.

What can parents do to support treatment at home?

Daily routines can make medical treatment more manageable and help children remain active.

Encourage comfortable movement

Regular physical activity helps maintain joint mobility. Children should follow the exercise program recommended by their healthcare team and discuss activities that repeatedly cause pain or swelling.

Support healthy posture

Comfortable seating, appropriate desk height, and regular changes in position can help reduce discomfort during schoolwork or computer use.

Children who sit for long periods may benefit from short movement breaks.

Provide balanced nutrition

A varied diet supports normal growth, bone health, and general well-being. Meals should provide appropriate amounts of protein, calcium, vitamin D, and other essential nutrients.

No particular food or diet has been shown to cure juvenile ankylosing spondylitis. Dietary supplements should not replace prescribed treatment.

Work with the school

Joint pain and fatigue may affect attendance, physical education, or the ability to sit comfortably for long periods.

Parents can discuss practical adjustments with teachers, such as movement breaks, suitable seating, or modified physical activities when symptoms interfere with participation.

Keep follow-up appointments

Regular specialist visits allow the healthcare team to review pain, joint movement, daily functioning, growth, medication safety, and treatment response.

Families should report new symptoms or changes in the child's ability to move or participate in normal activities.

Can early treatment prevent permanent joint damage?

Early treatment can reduce ongoing inflammation and may help limit long-term joint damage. It also supports mobility during important years of childhood growth and development.

However, treatment cannot guarantee that structural changes will never occur. The course of juvenile ankylosing spondylitis differs among children.

Some children achieve good symptom control and maintain normal daily activities, while others need changes in treatment over time.

Continued assessment is important because inflammation may remain active even when symptoms temporarily improve.

When should a child see a doctor?

Medical assessment is appropriate when a child has persistent or recurring joint pain, unexplained swelling, morning stiffness, or difficulty walking and participating in usual activities.

A pediatric rheumatology assessment is particularly useful when these symptoms continue without an obvious explanation or when inflammatory arthritis is suspected.

Some symptoms need faster attention. Sudden eye pain, redness, light sensitivity, or changes in vision require urgent medical evaluation. A hot, swollen joint accompanied by fever or inability to bear weight also warrants urgent assessment because infection and other serious causes need to be considered.

With a coordinated treatment plan, many children with juvenile ankylosing spondylitis can manage inflammation, remain physically active, and continue participating in school and everyday life.

Frequently Asked Questions

Common questions from parents and caregivers about the causes, treatment, and long-term outlook of juvenile ankylosing spondylitis.

Can a child develop ankylosing spondylitis without the HLA-B27 gene?

Yes. Although HLA-B27 is strongly associated with juvenile ankylosing spondylitis, some affected children do not carry this genetic marker. Doctors consider symptoms, examination findings, family history, and imaging when evaluating the condition.

Can juvenile ankylosing spondylitis be completely cured?

There is currently no cure for juvenile ankylosing spondylitis. However, medicines, physical therapy, and ongoing care can control inflammation, improve joint movement, and help children maintain daily activities. Some children experience periods of very low disease activity or remission.

Can children with juvenile ankylosing spondylitis play sports?

Many children can participate in physical activities and sports when their symptoms are well controlled. Swimming, walking, and other low-impact activities may be comfortable options. A pediatric rheumatologist or physical therapist can recommend suitable activities and modifications based on joint involvement and current symptoms.

Does juvenile ankylosing spondylitis always cause spinal fusion?

No. Spinal fusion is a possible complication of long-standing disease, but it does not occur in every child. Early recognition, effective inflammation control, and appropriate physical therapy may help protect mobility and reduce the risk of lasting complications.

Will a child with juvenile ankylosing spondylitis need medicine for life?

Not necessarily. Treatment duration depends on how active the disease remains and how well it responds to medicines. Some children need long-term medication, while others may have periods of remission. Any reduction or change in treatment should be guided by a pediatric rheumatologist rather than stopping medication independently.

Citations

  1. Arthritis Foundation — Juvenile Ankylosing Spondylitis
  2. National Institute of Arthritis and Musculoskeletal and Skin Diseases — Ankylosing Spondylitis: Overview, Symptoms, and Causes
  3. National Institute of Arthritis and Musculoskeletal and Skin Diseases — Ankylosing Spondylitis: Diagnosis, Treatment, and Steps to Take
  4. Pediatric Orthopaedic Society of North America — Juvenile Spondyloarthropathy
  5. NHS — Ankylosing Spondylitis: Treatment
Share this article